Summary
The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
- Special District Governments
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Public and State Institutions of Higher Education
- Public and Indian Housing Authorities
- Unrestricted
- Independent School Districts
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- State Governments
- Small Businesses
- Native American Tribal Governments Federally Recognized
- City Or Township Governments
- Private Institutions of Higher Education
- Nonprofits Non Higher Education Without 501c3
- County Governments
- For Profit Organizations Other Than Small Businesses
Funding categories
- Consumer Protection
- Food and Nutrition
- Agriculture
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record